The use of a natural IgG transport system to deliver a mucosal vaccine is a step toward needle-free immunization.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ye, L. et al. Nat. Biotechnol. 29, 158–163 (2011).
Roopenian, D.C. & Akilesh, S. Nat. Rev. Immunol. 7, 715–725 (2007).
Baker, K. et al. Semin. Immunopathol. 31, 223–236 (2009).
Simister, N.E. & Mostov, K.E. Nature 337, 184–187 (1989).
Chaudhury, C. et al. J. Exp. Med. 197, 315–322 (2003).
Yoshida, M. et al. Immunity 20, 769–783 (2004).
Yoshida, M. et al. J. Clin. Invest. 116, 2142–2151 (2006).
Kiyono, H., Kunasawa, J., McGhee, J.R. & Mestecky, J. The Mucosal Immune System. in Fundamental Immunology (ed. Paul, W.E.) 983–1030 (Lippincott Williams & Wilkins, Philadelphia, 2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
McGhee, J. A mucosal gateway for vaccines. Nat Biotechnol 29, 136–138 (2011). https://doi.org/10.1038/nbt.1766
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1766
This article is cited by
-
Multiple mechanisms mediate enhanced immunity generated by mAb‐inactivated F. tularensis immunogen
Immunology & Cell Biology (2013)
-
Intranasal delivery to the brain
Nature Biotechnology (2011)